NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investors/Analysts Presentation on the Financial Results of the Company for the quarter and half year ended September 30, 202307-11-2023
07-11-2023
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023
unaudited financial results of the Company for the quarter and half year ended September 30, 202307-11-2023
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023
unaudited financial results of the Company for the quarter and half year ended September 30, 202307-11-2023
NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of Confirmation in lieu of Share Certificate(s) reported lost/misplaced07-11-2023
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management Personnel06-11-2023
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation about Investor conference participation02-11-2023
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call Intimation Q2 FY2430-10-2023
NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate(s)20-10-2023
NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of Confirmation / Share Certificate(s) in lieu of Share Certificate(s) reported lost/misplaced18-10-2023
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 ,inter alia, to consider and approve The Unaudited Financial Results of the Company For The Quarter And Half Year Ended September 30, 202311-10-2023